| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |